Efficacy of escitalopram in the treatment of social anxiety disorder: A meta-analysis versus placebo

Article English OPEN
Baldwin, D.; Asakura, S.; Koyama, T.; Hayano, T.; Hagino, A.; Reines, E.; Larsen, K.;
(2016)

Escitalopram is the most selective of the serotonin reuptake inhibitor (SSRI) antidepressants. We conducted a meta-analysis of placebo-controlled studies where escitalopram was used to treat patients with social anxiety disorder (SAD). Data from all randomised, double-b... View more
Share - Bookmark